Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019936338> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2019936338 abstract "Sulindac inhibits carcinogenesis via the mechanism that appears beyond cyclooxygenase inhibition. Recently sulindac has been identified as competitive inhibitors of aldo-keto reductase family 1B10 (AKR1B10). AKR1B10 is involved in the process of carbonyls, farnesyl and geranylgeranyl as well as retinal metabolisms, and these metabolic activities are important to carcinogenesis. However, there is no evidence on if inhibition of pancreatic carcinogenesis by sulindac is via inhibition of AKR1B10 and protein prenylation (i.e., Kras protein). To determine the effect of sulindac on pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice, five-week-old mice were fed with either AIN-93M diet or AIN-93M diet contained 200ppm sulindac (n=20 mice/group). Kaplan-Meier survival analysis with Log-Rank test was performed to analyze the effect of sulindac on animal survival from the development of pancreatic carcinoma. The results showed that average animal survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice was 143.7 ± 8.8 days; and with the sulindac 200ppm treatment, animal survival significantly increased to 168.0 ± 8.8 days (p Citation Format: Jie Liao, Yeon Tae Chung, Haonan Li, Wanying Zhang, Guang-Yu Yang. Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice by suppressing aldo-keto reductase family 1B10 (AKR1B10). [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 190. doi:10.1158/1538-7445.AM2013-190" @default.
- W2019936338 created "2016-06-24" @default.
- W2019936338 creator A5006641884 @default.
- W2019936338 creator A5018860020 @default.
- W2019936338 creator A5023667687 @default.
- W2019936338 creator A5058451144 @default.
- W2019936338 creator A5070100940 @default.
- W2019936338 date "2013-04-15" @default.
- W2019936338 modified "2023-10-17" @default.
- W2019936338 title "Abstract 190: Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice by suppressing aldo-keto reductase family 1B10 (AKR1B10)." @default.
- W2019936338 doi "https://doi.org/10.1158/1538-7445.am2013-190" @default.
- W2019936338 hasPublicationYear "2013" @default.
- W2019936338 type Work @default.
- W2019936338 sameAs 2019936338 @default.
- W2019936338 citedByCount "0" @default.
- W2019936338 crossrefType "proceedings-article" @default.
- W2019936338 hasAuthorship W2019936338A5006641884 @default.
- W2019936338 hasAuthorship W2019936338A5018860020 @default.
- W2019936338 hasAuthorship W2019936338A5023667687 @default.
- W2019936338 hasAuthorship W2019936338A5058451144 @default.
- W2019936338 hasAuthorship W2019936338A5070100940 @default.
- W2019936338 hasConcept C121608353 @default.
- W2019936338 hasConcept C126322002 @default.
- W2019936338 hasConcept C134651460 @default.
- W2019936338 hasConcept C181199279 @default.
- W2019936338 hasConcept C185592680 @default.
- W2019936338 hasConcept C2776241388 @default.
- W2019936338 hasConcept C2778484676 @default.
- W2019936338 hasConcept C2780210213 @default.
- W2019936338 hasConcept C502942594 @default.
- W2019936338 hasConcept C55493867 @default.
- W2019936338 hasConcept C555283112 @default.
- W2019936338 hasConcept C71924100 @default.
- W2019936338 hasConcept C86803240 @default.
- W2019936338 hasConcept C98274493 @default.
- W2019936338 hasConceptScore W2019936338C121608353 @default.
- W2019936338 hasConceptScore W2019936338C126322002 @default.
- W2019936338 hasConceptScore W2019936338C134651460 @default.
- W2019936338 hasConceptScore W2019936338C181199279 @default.
- W2019936338 hasConceptScore W2019936338C185592680 @default.
- W2019936338 hasConceptScore W2019936338C2776241388 @default.
- W2019936338 hasConceptScore W2019936338C2778484676 @default.
- W2019936338 hasConceptScore W2019936338C2780210213 @default.
- W2019936338 hasConceptScore W2019936338C502942594 @default.
- W2019936338 hasConceptScore W2019936338C55493867 @default.
- W2019936338 hasConceptScore W2019936338C555283112 @default.
- W2019936338 hasConceptScore W2019936338C71924100 @default.
- W2019936338 hasConceptScore W2019936338C86803240 @default.
- W2019936338 hasConceptScore W2019936338C98274493 @default.
- W2019936338 hasLocation W20199363381 @default.
- W2019936338 hasOpenAccess W2019936338 @default.
- W2019936338 hasPrimaryLocation W20199363381 @default.
- W2019936338 hasRelatedWork W1520185676 @default.
- W2019936338 hasRelatedWork W1586708178 @default.
- W2019936338 hasRelatedWork W1979933459 @default.
- W2019936338 hasRelatedWork W2005844816 @default.
- W2019936338 hasRelatedWork W2010319640 @default.
- W2019936338 hasRelatedWork W2051829536 @default.
- W2019936338 hasRelatedWork W2057367025 @default.
- W2019936338 hasRelatedWork W2065335954 @default.
- W2019936338 hasRelatedWork W2074115237 @default.
- W2019936338 hasRelatedWork W2093542574 @default.
- W2019936338 hasRelatedWork W2117151424 @default.
- W2019936338 hasRelatedWork W2382478903 @default.
- W2019936338 hasRelatedWork W2563303807 @default.
- W2019936338 hasRelatedWork W2567517258 @default.
- W2019936338 hasRelatedWork W2587667917 @default.
- W2019936338 hasRelatedWork W2741118380 @default.
- W2019936338 hasRelatedWork W2766728561 @default.
- W2019936338 hasRelatedWork W2799188700 @default.
- W2019936338 hasRelatedWork W2885953945 @default.
- W2019936338 hasRelatedWork W2958981879 @default.
- W2019936338 isParatext "false" @default.
- W2019936338 isRetracted "false" @default.
- W2019936338 magId "2019936338" @default.
- W2019936338 workType "article" @default.